Literature DB >> 31315130

Striatal volume and functional connectivity correlate with weight gain in early-phase psychosis.

Philipp Homan1,2,3, Miklos Argyelan4,5,6, Christina L Fales5, Anita D Barber5, Pamela DeRosse4,5,6, Philip R Szeszko7, Delbert G Robinson4,5,6, Todd Lencz4,5,6, Anil K Malhotra4,5,6.   

Abstract

Second-generation antipsychotic drugs (SGAs) are essential in the treatment of psychotic disorders, but are well-known for inducing substantial weight gain and obesity. Critically, weight gain may reduce life expectancy for up to 20-30 years in patients with psychotic disorders, and prognostic biomarkers are generally lacking. Even though other receptors are also implicated, the dorsal striatum, rich in dopamine D2 receptors, which are antagonized by antipsychotic medications, plays a key role in the human reward system and in appetite regulation, suggesting that altered dopamine activity in the striatal reward circuitry may be responsible for increased food craving and weight gain. Here, we measured striatal volume and striatal resting-state functional connectivity at baseline, and weight gain over the course of 12 weeks of antipsychotic treatment in 81 patients with early-phase psychosis. We also included a sample of 58 healthy controls. Weight measurements were completed at baseline, and then weekly for 4 weeks, and every 2 weeks until week 12. We used linear mixed models to compute individual weight gain trajectories. Striatal volume and whole-brain striatal connectivity were then calculated for each subject, and used to assess the relationship between striatal structure and function and individual weight gain in multiple regression models. Patients had similar baseline weights and body mass indices (BMI) compared with healthy controls. There was no evidence that prior drug exposure or duration of untreated psychosis correlated with baseline BMI. Higher left putamen volume and lower sensory motor connectivity correlated with the magnitude of weight gain in patients, and these effects multiplied when the structure-function interaction was considered in an additional exploratory analysis. In conclusion, these results provide evidence for a correlation of striatal structure and function with antipsychotic-induced weight gain. Lower striatal connectivity was associated with more weight gain, and this relationship was stronger for higher compared with lower left putamen volumes.

Entities:  

Mesh:

Year:  2019        PMID: 31315130      PMCID: PMC6785100          DOI: 10.1038/s41386-019-0464-y

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  60 in total

1.  Quantitative morphology of the caudate and putamen in patients with cocaine dependence.

Authors:  L K Jacobsen; J N Giedd; C Gottschalk; T R Kosten; J H Krystal
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

Review 2.  Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents.

Authors:  Igor Elman; David Borsook; Scott E Lukas
Journal:  Neuropsychopharmacology       Date:  2006-03-15       Impact factor: 7.853

Review 3.  Circular analysis in systems neuroscience: the dangers of double dipping.

Authors:  Nikolaus Kriegeskorte; W Kyle Simmons; Patrick S F Bellgowan; Chris I Baker
Journal:  Nat Neurosci       Date:  2009-05       Impact factor: 24.884

4.  Compulsive eating and weight gain related to dopamine agonist use.

Authors:  Melissa J Nirenberg; Cheryl Waters
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

5.  Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers.

Authors:  Dana M Small; Marilyn Jones-Gotman; Alain Dagher
Journal:  Neuroimage       Date:  2003-08       Impact factor: 6.556

6.  Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals.

Authors:  Yvonne Rothemund; Claudia Preuschhof; Georg Bohner; Hans-Christian Bauknecht; Randolf Klingebiel; Herta Flor; Burghard F Klapp
Journal:  Neuroimage       Date:  2007-05-18       Impact factor: 6.556

7.  Widespread reward-system activation in obese women in response to pictures of high-calorie foods.

Authors:  Luke E Stoeckel; Rosalyn E Weller; Edwin W Cook; Donald B Twieg; Robert C Knowlton; James E Cox
Journal:  Neuroimage       Date:  2008-03-04       Impact factor: 6.556

8.  A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.

Authors:  Delbert G Robinson; Juan A Gallego; Majnu John; Lauren A Hanna; Jian-Ping Zhang; Michael L Birnbaum; Jessica Greenberg; Melissa Naraine; Bart D Peters; Robert K McNamara; Anil K Malhotra; Philip R Szeszko
Journal:  Schizophr Res       Date:  2018-09-19       Impact factor: 4.939

9.  Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients.

Authors:  Hans Rasmussen; Bjørn H Ebdrup; B Oranje; Lars H Pinborg; Gitte M Knudsen; Birte Glenthøj
Journal:  Int J Neuropsychopharmacol       Date:  2014-05-15       Impact factor: 5.176

10.  Dissociated Accumbens and Hippocampal Structural Abnormalities across Obesity and Alcohol Dependence.

Authors:  Tom B Mole; Elijah Mak; Yee Chien; Valerie Voon
Journal:  Int J Neuropsychopharmacol       Date:  2016-09-21       Impact factor: 5.176

View more
  1 in total

1.  Examining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance.

Authors:  Maria S Neumeier; Stephanie Homan; Stefan Vetter; Erich Seifritz; John M Kane; Maximilian Huhn; Stefan Leucht; Philipp Homan
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.